Showing results (821-830 of 2,691) with videos related to
Sort By:
Pageof 270
The Lancet. Infectious Diseases|May 23, 2018
The dynamic role of dengue cross-reactive immunity: changing the approach to defining vaccine safety and efficacyKathryn B Anderson, Timothy P Endy, Stephen J ThomasThe Lancet. Infectious Diseases|April 21, 2018
Efficacy and tolerability of triple drug therapy with albendazole, pyrantel pamoate, and oxantel pamoate compared with albendazole plus oxantel pamoate, pyrantel pamoate plus oxantel pamoate, and mebendazole plus pyrantel pamoate and oxantel pamoate against hookworm infections in school-aged children in Laos: a randomised, single-blind trialWendelin Moser, Somphou Sayasone, Syda Xayavong, et al.The Lancet. Infectious Diseases|October 10, 2021
Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trialValentijn A Schweitzer, Inger van Heijl, Wim G Boersma, et al.The Lancet. Infectious Diseases|October 21, 2021
Effect of change in vaccine schedule on pertussis epidemiology in France: a modelling and serological studyJuliette Paireau, Sophie Guillot, Fatima Aït El Belghiti, et al.The Lancet. Infectious Diseases|October 2, 2021
Spinal epidural abscess caused by Aspergillus spp masquerading as spinal tuberculosis in a person with HIVRoxanne Rule, Barend Mitton, Nelesh P Govender, et al.The Lancet. Infectious Diseases|September 25, 2021
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance studyEric J Haas, John M McLaughlin, Farid Khan, et al.The Lancet. Infectious Diseases|September 26, 2021
Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trialVivek Shinde, Iksung Cho, Joyce S Plested, et al.The Lancet. Infectious Diseases|October 4, 2021
The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysisMaria Krutikov, Lena Faust, Vladyslav Nikolayevskyy, et al.The Lancet. Infectious Diseases|April 25, 2022
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative designAziz Sheikh, Steven Kerr, Mark Woolhouse, et al.The Lancet. Infectious Diseases|June 15, 2019
The burden of Legionnaires' disease in New Zealand (LegiNZ): a national surveillance studyPatricia C Priest, Sandy Slow, Stephen T Chambers, et al.Pageof 270